An Intelligent Nanomachine Guided by DNAzyme Logic System for Precise Chemodynamic Therapy DOI
Zhao Wang, Jie Yang, Geng Qin

et al.

Angewandte Chemie International Edition, Journal Year: 2022, Volume and Issue: 61(38)

Published: Aug. 1, 2022

Abstract The intelligent nanomachine usually has a control center to carry out self‐regulation. Unfortunately, most of the nanomaterials for chemodynamic therapy (CDT) do not have such sense and process chemical or biological signals, which greatly weakens selectivity efficiency CDT. To address this problem, here an was constructed with DNAzyme logic gate as center, metal organic framework actuator. well‐designed showed enhanced killing effect on cancer cells but posed no harm normal cells, acquiring better than clinical chemotherapy drugs (doxorubicin cisplatin). best our knowledge, is first reported cell‐specific CDT by guidance gate. Our work highlights great potential DNAzymes in response networks, extends implementation nanomachines precision medicine.

Language: Английский

NANOTECHNOLOGY-DRIVEN THERAPEUTICS FOR LIVER CANCER: CLINICAL APPLICATIONS AND PHARMACEUTICAL INSIGHTS DOI Open Access
Lokeshvar Ravikumar,

RAMAIYAN VELMURUGAN,

Nithin Vidiyala

et al.

Asian Journal of Pharmaceutical and Clinical Research, Journal Year: 2025, Volume and Issue: unknown, P. 8 - 26

Published: Feb. 7, 2025

Hepatocellular carcinoma (HCC) represents a significant threat to global health and is responsible for mortality rates worldwide. Conventional treatment options such as surgery chemotherapy have inherent limitations. In order remedy these deficits, the development of novel therapeutic strategies essential. Nanomedicines shown promise in HCC they offer improved stability, controlled release, increased drug loading capacity. This review explores application nanoconstructs treatment, including active passive targeting strategies. addition, liver cell approaches, moieties, conjugation chemistry surface functionalization are investigated. A compact overview various approaches also given.

Language: Английский

Citations

2

Polyprodrug Nanomedicines: An Emerging Paradigm for Cancer Therapy DOI
Kuikun Yang, Zhiqing Yang, Guocan Yu

et al.

Advanced Materials, Journal Year: 2021, Volume and Issue: 34(6)

Published: Oct. 25, 2021

Abstract Nanomedicines have the potential to provide advanced therapeutic strategies in combating tumors. Polymer‐prodrug‐based nanomedicines are particularly attractive cancer therapies owing maximum drug loading, prolonged blood circulation, and reduced premature leakage side effects comparison with conventional nanomaterials. However, difficulty precisely tuning composition loading of polymer–drug conjugates leads batch‐to‐batch variations prodrugs, thus significantly restricting their clinical translation. Polyprodrug inherit numerous intrinsic advantages exhibit well‐controlled via direct polymerization monomers, representing a promising nanomedicine for tumor therapies. In this review, recent advances development polyprodrug summarized elimination. Various types corresponding properties first summarized. The unique key roles various further highlighted. Finally, current challenges perspectives on future research discussed.

Language: Английский

Citations

101

A Hybrid Supramolecular Polymeric Nanomedicine for Cascade‐Amplified Synergetic Cancer Therapy DOI
Kai Yang, Shaolong Qi, Xinyang Yu

et al.

Angewandte Chemie International Edition, Journal Year: 2022, Volume and Issue: 61(27)

Published: April 5, 2022

Supramolecular nanomedicines have shown great merits in cancer therapy, but their clinical translation is hampered by monotonous therapeutic modality and unsatisfactory antitumor performance. Herein, a hybrid supramolecular polymeric nanomedicine (SNPs) developed based on β-cyclodextrin/camptothecin (CPT) host-guest molecular recognition iron-carboxylate coordination. Iron ions stabilizing SNPs catalyze the conversion of intracellular hydrogen peroxide into highly toxic hydroxyl radical through Fenton reaction, which further cleaves thioketal linker monomer to release potent CPT, thus amplifying efficacy combining chemodynamic therapy chemotherapy. The combination stimulates immunity promotes intratumoral infiltration cytotoxic T lymphocytes triggering immunogenic cell death. In synergy with PD-L1 checkpoint blockade, enables enhanced immune long-term tumor remission.

Language: Английский

Citations

67

Recent advances in augmenting Fenton chemistry of nanoplatforms for enhanced chemodynamic therapy DOI
Shulan Li, Xu Chu, Hongli Dong

et al.

Coordination Chemistry Reviews, Journal Year: 2022, Volume and Issue: 479, P. 215004 - 215004

Published: Dec. 31, 2022

Language: Английский

Citations

58

An Intelligent Nanomachine Guided by DNAzyme Logic System for Precise Chemodynamic Therapy DOI
Zhao Wang, Jie Yang, Geng Qin

et al.

Angewandte Chemie International Edition, Journal Year: 2022, Volume and Issue: 61(38)

Published: Aug. 1, 2022

Abstract The intelligent nanomachine usually has a control center to carry out self‐regulation. Unfortunately, most of the nanomaterials for chemodynamic therapy (CDT) do not have such sense and process chemical or biological signals, which greatly weakens selectivity efficiency CDT. To address this problem, here an was constructed with DNAzyme logic gate as center, metal organic framework actuator. well‐designed showed enhanced killing effect on cancer cells but posed no harm normal cells, acquiring better than clinical chemotherapy drugs (doxorubicin cisplatin). best our knowledge, is first reported cell‐specific CDT by guidance gate. Our work highlights great potential DNAzymes in response networks, extends implementation nanomachines precision medicine.

Language: Английский

Citations

57